MONTPELLIER, France, Sept. 11, 2015 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, announced that it has entered an exclusive distribution contract in Turkey with Medikon, a company specialized in distributing and marketing innovative robotic devices, with a strong focus in the neurosurgery market. MEDTECH also announced the first sale of a ROSA™ robotic surgery system in Turkey through its new agreement with Medikon.
"We are very pleased with this new commercial partnership with Medikon. This distribution contract and first sale of the ROSA™ robotic surgery system in Turkey allow Medtech to extend its international potential into a large market. The Turkish medical device market grew at a compound annual rate of 2.4% over the 2008-2013 period and has a promising outlook for growth for the coming years," said Bertin Nahum, CEO and Founder of Medtech.
About MEDTECH
Founded in 2002 by Bertin NAHUM and based near Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment.
In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada.
In 2013 Medtech received the "European Company of the Year Award" in the "robotic neurosurgery" category from Frost & Sullivan.
In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine.
In October 2014, MEDTECH won the "Révélation" prize in the Mediterranean Deloitte Technology Fast 50 Awards.